Dr. Katz leads the Cancer Surveillance & Outcomes Research Team (www.cansort.org), an interdisciplinary group of investigators dedicated to researching cancer quality of care. Our investigators are located at five universities and cancer centers throughout the United States and seek to understand and improve how patients and their providers communicate and make decisions about cancer treatments. CanSORT studies the quality of cancer care across the continuum of care from prevention to survivorship. The team also develops and evaluates interventions to improve cancer care including decision tools for patients and clinicians and dissemination strategies to more quickly move research results to the provider community.
Kurian AW, Ward KC, Hamilton AS, Deapen DM, Abrahamse P, Bondarenko I, Li Y, Hawley ST, Morrow M, Jagsi R, Katz SJ.
Recent Trends in Chemotherapy Use and Oncologists’ Treatment Recommendations for Early-Stage Breast Cancer
Kurian AW, Bondarenko I, Jagsi R, Friese CR, McLeod MC, Hawley ST, Hamilton AS, Ward KC, Katz SJ. JNCI: Journal of the National Cancer Institute 1 May 2018;110(5):493-500.
Katz SJ, Ward KC, Hamilton AS, McLeod MC, Wallner LP, Morrow M, Jagsi R, Hawley ST, Kurian AW. J Clin Oncol 20 April 2018;36(12):1218-1224.
Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy For Women With Breast Cancer
Katz SJ, Hawley ST, Hamilton AS, Ward KC, Morrow M, Jagsi R, Hofer TP. JAMA Surg. 1 January 2018;153(1):29-36.
Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management
Morrow M, Abrahamse P, Hofer TP, Ward KC, Hamilton AS, Kurian AW, Katz SJ, Jagsi R. JAMA Oncol 1 October 2017;3(10):1352-1357.